Jifa Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 28

Top Topics

Tyrosine Kinase

Top Venues

Journal of medicinal chemistry

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Li Chen, Wuyu Mao, Changyu Ren, Jinqi Li, Jifa Zhang
Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles. Journal of medicinal chemistry 67 (1) (2024)
Li Chen, Wuyu Mao, Changyu Ren, Jinqi Li, Jifa Zhang
Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles. Journal of medicinal chemistry 67 (1) (2024)
Yuming Zhang, Lianhai Shan, Wentao Tang, Yating Ge, ChengXian Li, Jifa Zhang
Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications. Journal of medicinal chemistry (2024)
Li Chen, Wuyu Mao, Changyu Ren, Jinqi Li, Jifa Zhang
Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles. Journal of medicinal chemistry (2024)
Yuming Zhang, Lianhai Shan, Wentao Tang, Yating Ge, ChengXian Li, Jifa Zhang
Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications. Journal of medicinal chemistry 67 (7) (2024)
Li Chen, Wuyu Mao, Changyu Ren, Jinqi Li, Jifa Zhang
Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles. Journal of medicinal chemistry 67 (1) (2024)
Xinqi Liang, Ruixian Chen, Chengdi Wang, Yu-Xi Wang, Jifa Zhang
Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects. Journal of medicinal chemistry (2024)
Chunlin Qian, Xiaoxue Li, Jifa Zhang, Yu-Xi Wang
Small Molecular Inhibitors That Target ATM for Drug Discovery: Current Research and Potential Prospective. Journal of medicinal chemistry (2024)
Yuming Zhang, Lianhai Shan, Wentao Tang, Yating Ge, ChengXian Li, Jifa Zhang
Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications. Journal of medicinal chemistry 67 (7) (2024)
Lun Tan, Chengyong Wu, Jifa Zhang, Quanwei Yu, Xiye Wang, Lele Zhang, Meiyi Ge, Zhijia Wang, Liang Ouyang, Yu-Xi Wang
Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site. Journal of medicinal chemistry (2023)
Lun Tan, Chengyong Wu, Jifa Zhang, Quanwei Yu, Xiye Wang, Lele Zhang, Meiyi Ge, Zhijia Wang, Liang Ouyang, Yu-Xi Wang
Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site. Journal of medicinal chemistry 66 (5) (2023)
Yijia Chen, Yu-Xi Wang, Jiaxing Wang, Zhilan Zhou, Shu Cao, Jifa Zhang
Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects. Journal of medicinal chemistry 66 (4) (2023)
Wen Shuai, Faqian Bu, Yumeng Zhu, Yongya Wu, Huan Xiao, Xiaoli Pan, Jifa Zhang, Qiu Sun, Guan Wang, Liang Ouyang
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease. Journal of medicinal chemistry (2023)
Wen Shuai, Faqian Bu, Yumeng Zhu, Yongya Wu, Huan Xiao, Xiaoli Pan, Jifa Zhang, Qiu Sun, Guan Wang, Liang Ouyang
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease. Journal of medicinal chemistry 66 (2) (2023)
Yang Li, Yun Liu, Dan Zhang, Juncheng Chen, Gaoxia Yang, Pan Tang, Chengcan Yang, Jie Liu, Jifa Zhang, Liang Ouyang
Discovery, Synthesis, and Evaluation of Novel Dual Inhibitors of a Vascular Endothelial Growth Factor Receptor and Poly(ADP-Ribose) Polymerase for BRCA Wild-Type Breast Cancer Therapy. Journal of medicinal chemistry (2023)
Tingting Hu, Jifa Zhang, Jiaxing Wang, Leihao Sha, Yilin Xia, Tyler C Ortyl, Xiaohe Tian, Lei Chen
Correction to "Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies". Journal of medicinal chemistry (2023)
Wen Shuai, Faqian Bu, Yumeng Zhu, Yongya Wu, Huan Xiao, Xiaoli Pan, Jifa Zhang, Qiu Sun, Guan Wang, Liang Ouyang
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease. Journal of medicinal chemistry 66 (2) (2023)
Lun Tan, Chengyong Wu, Jifa Zhang, Quanwei Yu, Xiye Wang, Lele Zhang, Meiyi Ge, Zhijia Wang, Liang Ouyang, Yu-Xi Wang
Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site. Journal of medicinal chemistry 66 (5) (2023)
Yijia Chen, Yu-Xi Wang, Jiaxing Wang, Zhilan Zhou, Shu Cao, Jifa Zhang
Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects. Journal of medicinal chemistry (2023)
Wen Shuai, Faqian Bu, Yumeng Zhu, Yongya Wu, Huan Xiao, Xiaoli Pan, Jifa Zhang, Qiu Sun, Guan Wang, Liang Ouyang
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease. Journal of medicinal chemistry 66 (2) (2023)
Yijia Chen, Yu-Xi Wang, Jiaxing Wang, Zhilan Zhou, Shu Cao, Jifa Zhang
Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects. Journal of medicinal chemistry 66 (4) (2023)
Tingting Hu, Jifa Zhang, Jiaxing Wang, Leihao Sha, Yilin Xia, Tyler C Ortyl, Xiaohe Tian, Lei Chen
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies. Journal of medicinal chemistry (2023)
Yijia Chen, Yu-Xi Wang, Jiaxing Wang, Zhilan Zhou, Shu Cao, Jifa Zhang
Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects. Journal of medicinal chemistry 66 (4) (2023)
Lun Tan, Chengyong Wu, Jifa Zhang, Quanwei Yu, Xiye Wang, Lele Zhang, Meiyi Ge, Zhijia Wang, Liang Ouyang, Yu-Xi Wang
Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site. Journal of medicinal chemistry 66 (5) (2023)
Wentao Tang, Congcong Lin, Quanwei Yu, Dan Zhang, Yun Liu, Lele Zhang, Zhilan Zhou, Jifa Zhang, Liang Ouyang
Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery. Journal of medicinal chemistry (2023)
Yingxu Fang, Jiaxing Wang, Min Zhao, Qinwen Zheng, Changyu Ren, Yu-Xi Wang, Jifa Zhang
Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy. Journal of medicinal chemistry 65 (17) (2022)
Kunyu Shi, Jifa Zhang, Enda Zhou, Jiaxing Wang, Yu-Xi Wang
Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities. Journal of medicinal chemistry 65 (22) (2022)
Changyu Ren, Xiaohong Gan, Houfeng Zhou, Jinqi Li, Jifa Zhang
Molecular glues targeting protein degradation pathways for drug discovery. Future medicinal chemistry (2021)